Skip to content

Opening book details…

About this Medicine article

Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin's lymphoma: a phase 1, open-label, dose-escalation study by Younes, Anas; Connors, Joseph M; Park, Steven I; Fanale, Michelle; O'Meara, Megan M; Hunder, Naomi N; Huebner, Dirk; Ansell, Stephen M is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Younes, Anas; Connors, Joseph M; Park, Steven I; Fanale, Michelle; O'Meara, Megan M; Hunder, Naomi N; Huebner, Dirk; Ansell, Stephen M
Publisher
The Lancet; Elsevier ; The Lancet Publishing Group; Elsevier BV (ISSN 1470-2045)
Published
2013
Language
EN
Field
Medicine (Health Sciences)